Prm47 - Understanding Key Value Drivers of a Novel Treatment in Management of Familial Chylomicronemia Syndrome

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.2170
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Two Case Reports of Familial Chylomicronemia Syndrome

Case Reports in Pediatrics
2012English

Assessing Cost-Effectiveness and Key Value Drivers of Adjuvant Triglyceride Lowering Therapy in Management of Patients With a Rare Genetic Syndrome

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2017English

The Burden of Familial Chylomicronemia Syndrome: Results From the Global IN-FOCUS Study

Journal of Clinical Lipidology
Internal MedicineNutritionCardiologyEndocrinologyCardiovascular MedicineDieteticsMetabolismDiabetes
2018English

Pnd122 - Health State Utilities Associated With Familial Chylomicronemia Syndrome (Fcs), a Rare Genetic Disorder

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

The Role of Value Drivers in Value-Based Management Concept

Herald UNU. International Economic Relations And World Economy
2019English

A Review and a Conceptual Framework of the Key Value Drivers of Mass Customisation

International Journal of Technology Marketing
MarketingComputer Science Applications
2013English

Clinical and Biochemical Features of Different Molecular Etiologies of Familial Chylomicronemia

Journal of Clinical Lipidology
Internal MedicineNutritionCardiologyEndocrinologyCardiovascular MedicineDieteticsMetabolismDiabetes
2018English

Employee Subjectivity as a Key Value in Management

Annales. Etyka w Życiu Gospodarczym
2016English

Heterozygote of Lipoprotein Lipase Deficiency Presenting Chylomicronemia Syndrome

The Journal of Japan Atherosclerosis Society
1990English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy